Fetal Heart Interventricular Septum in Fetuses of Diabetic Mothers
Relation Between Fetal Heart Interventricular Septum Size and Gestational Diabetes Mellitus Control. a Prospective Trial
Relation Between Fetal Heart Interventricular Septum Size and Gestational Diabetes Mellitus Control. a Prospective Trial
Sponsor study identifier
observational
300
1 country
1
Study Start
May 2013
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The investigators asume that the measurement of the fetal heart interventricular septum can serve as a good tool to predict glucose control in pregnant patients with diabetes mellitus. The investigators will measure the septum width in patients with Diabetes and will correlate to standard measurements of the glucuse levels.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 9, 2013
Actual (reported)May 2013
Date type not reportedThis date has not been verified as actual or estimated.
May 3, 2013
Actual (reported)May 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
width of fetal interventricula heart septum
The investigator will assess the width of the fetal interventricular septum in patients with diabetes.
2 years
glucose control in patients with normal and abnormal interventricular septal width
2 years
Our cohort will include all consequtive women with Diabetes Mellitus atending our clinic
All consequtive pregnant women with Diabetes Mellitus - Gestational and non Gestational
Hillel Yaffe Medical Center
Hadera, 38100, Israel
Alon Shrim, MD
Hillel Yaffe Medical Center
First Submitted
April 9, 2013
First Posted
May 3, 2013
Study Start
May 2013
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 2014
Estimated (date passed)Detection of Risk Factors for Fetal Anomalies in a Rural Hospital Population
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
May 3, 2013
Record last verified: 2013-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: